FINWIRES · TerminalLIVE
FINWIRES

HKG:9926

4 stories mentioning HKG:9926Updated 8d ago

Every FINWIRES story that references HKG:9926, newest first.

Asia

Akeso's Trustee, Senior Management to Buy Back Shares

Akeso's (HKG:9926) board approved a plan for a trustee to buy back up to HK$200 million ordinary shares under a 2021 restricted share unit scheme, according to a Thursday Hong Kong bourse filing.The shares will be repurchased from the open market, the drug company said.Additionally, Chairperson and CEO Xia Yu, Chief Financial Officer Bing C. Wang, and three executive directors plan to increase their shareholdings in the company.The parties will purchase a total of up to HK$50 million shares from the open market.

HKG:9926
Asia

Akeso Board Approves HK$200 Million Share Purchase Plan

Akeso's (HKG:9926) board approved a plan to purchase up to HK$200 million of its shares on the open market, according to a Thursday Hong Kong bourse filing.The purchases will be conducted through the trustee of the company's 2021 restricted share unit scheme and will be funded by existing cash resources.

HKG:9926
Asia

Nomura Adjusts Akeso's Price Target to HK$142.50 From HK$142.75, Keeps at Buy

Akeso (HKG:9926) has an average rating of buy and mean price target of HK$175.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

HKG:9926
Asia

Nomura Adjusts Akeso's Price Target to HK$142.75 From HK$112.73, Keeps at Neutral

Akeso (HKG:9926) has an average rating of buy and mean price target of HK$172.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

HKG:9926

Track with the FINWIRES app suite